Showing 1 - 7 results of 7 for search 'Thomas O Carpenter', query time: 0.03s Refine Results
  1. 1
    Hypophosphatemic rickets: An unexplained early feature of craniometaphyseal dysplasia

    Hypophosphatemic rickets: An unexplained early feature of craniometaphyseal dysplasia by Julio Soto Barros, Demetrios Braddock, Thomas O. Carpenter

    Published 2023-12-01
    Get full text
    Article
  2. 2
    Single Dose Of Bisphosphonate To Treat Infantile Hypercalcemia

    Single Dose Of Bisphosphonate To Treat Infantile Hypercalcemia by Neha S. Patel, DO, Thomas O. Carpenter, MD, Myron Genel, MD

    Published 2017-01-01
    Get full text
    Article
  3. 3
    Corrigendum to “Skeletal disease in a father and daughter with a novel monoallelic WNT1 mutation” [Bone Rep. 9 (2018) 154-158]

    Corrigendum to “Skeletal disease in a father and daughter with a novel monoallelic WNT1 mutation” [Bone Rep. 9 (2018) 154-158] by Kathleen Timme, Elizabeth Sanchez Rangel, Qianying Yuan, Dianqing Wu, Thomas O. Carpenter, Karl Insogna

    Published 2020-06-01
    Get full text
    Article
  4. 4
    Excluding Digenic Inheritance of <i>PGAP2</i> and <i>PGAP3</i> Variants in Mabry Syndrome (OMIM 239300) Patient: Phenotypic Spectrum Associated with <i>PGAP2</i> Gene Variants in Hyperphosphatasia with Mental Retardation Syndrome-3 (HPMRS3)

    Excluding Digenic Inheritance of <i>PGAP2</i> and <i>PGAP3</i> Variants in Mabry Syndrome (OMIM 239300) Patient: Phenotypic Spectrum Associated with <i>PGAP2</i> Gene Variants in H... by Miles D. Thompson, Xueying Li, Michele Spencer-Manzon, Danielle M. Andrade, Yoshiko Murakami, Taroh Kinoshita, Thomas O. Carpenter

    Published 2023-01-01
    Get full text
    Article
  5. 5
    Effect of four monthly doses of a human monoclonal anti-FGF23 antibody (KRN23) on quality of life in X-linked hypophosphatemia

    Effect of four monthly doses of a human monoclonal anti-FGF23 antibody (KRN23) on quality of life in X-linked hypophosphatemia by Mary D. Ruppe, Xiaoping Zhang, Erik A. Imel, Thomas J. Weber, Mark A. Klausner, Takahiro Ito, Maria Vergeire, Jeffrey S. Humphrey, Francis H. Glorieux, Anthony A. Portale, Karl Insogna, Munro Peacock, Thomas O. Carpenter

    Published 2016-12-01
    Get full text
    Article
  6. 6
    An Unusual Case of Rickets and How Whole Exome Sequencing Helped to Correct a Diagnosis

    An Unusual Case of Rickets and How Whole Exome Sequencing Helped to Correct a Diagnosis by Patricia R. Peter, MD, Catherine A. Brownstein, PhD, Gang-Qing Yao, MD, Elizabeth A. Olear, MS, MA, Christine A. Simpson, MS, MT (ASCP), Pankaj B. Agrawal, MD, MMSC, Thomas O. Carpenter, MD, Karl L. Insogna, MD

    Published 2016-01-01
    Get full text
    Article
  7. 7
    Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension

    Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension by Karine Briot, Rachel K Crowley, Maria Luisa Brandi, Stuart H Ralston, Han-Wook Yoo, Peter Kamenický, Takuo Kubota, Nobuaki Ito, Martine Cohen-Solal, Richard Keen, Angela Williams, Muhammad K Javaid, Hiroyuki Tanaka, Robin H Lachmann, Karl Insogna, Richard Eastell, Yasuhiro Takeuchi, Anthony A Portale, Thomas O Carpenter, Hae Ii Cheong, Yasuo Imanishi, Steven Ing, Suzanne Jan de Beur, Farzana Perwad, Pisit Pitukcheewanont, Thomas J Weber, Annabel Nixon, Mark Nixon, Erik A Imel

    Published 2021-11-01
    Get full text
    Article

Search Tools: